Skip to content
Aussie8 – Lifestyle
Author:
Absci Corporation
Absci to Participate in Upcoming Investor Conferences
September 1, 2026
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
August 12, 2026
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
July 14, 2026
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
June 24, 2026
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
June 24, 2026
Absci to Participate in Upcoming Investor Conferences
May 20, 2026
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
May 8, 2026
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
April 23, 2026
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
1
2
Next Page
→